AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CASPOFUNGIN ACETATE

10 registrations across 3 African markets— 10 active

Markets with CASPOFUNGIN ACETATE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Casfung 50
Powder For Concentrate For Solution For Infus
🇰🇪KenyaGlenmark Pharmaceuticals Ltd.activeSept 2027
Bifungin-50 Injection
Injection
🇰🇪KenyaIndasi Lifescience Pvt. LtdactiveJan 2027
CASPOKEN 70 INJECTION
Powder For Injection
🇰🇪KenyaKILITCH DRUGS (INDIA) LTDactiveJan 2027
CASPOKEN 50 INJECTION
Powder For Injection
🇰🇪KenyaKILITCH DRUGS (INDIA) LTDactiveJan 2027
CASFOLRED 70🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
CASPOFUNGIN DRL 50🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
CASFOLRED 50🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
CASPOFUNGIN DRL 70🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
CASPOFUNGIN ACETATE
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaCIPLA LTD.active
CASPOFUNGIN ACETATE
PARENTERAL ORDINARY DRY VIALS
🇺🇬UgandaCIPLA LTD.active

CASPOFUNGIN ACETATE in Africa — Regulatory Overview

CASPOFUNGIN ACETATE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, South Africa, Uganda. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.